Browsing: Wegovy

Novo Nordisk’s CEO sought to reassure investors that its Wegovy pill can drive profitable growth despite lower prices, as investors sent the drugmaker’s shares lower following quarterly results

Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II diabetes [T2D]) and Wegovy (for obesity)

The sticker price of Wegovy can run north of $1,000 a month. Starting July 1, 2026, some Medicare beneficiaries can snag it for $50 a month. The catch is the qualifying list, which is narrower than the headlines suggest, and the exclusions that will surprise the people who assume they are first in line

As the use of glucagon-like peptide-1 (GLP-1) class obesity treatments such as Wegovy and Mounjaro increases, reports of side effects are drawing attention. A wide range of issues is being reported, from the well-known gastrointestinal problems to hair loss

[Sportschosun Reporter Kim Su-hyun] Shindong of Super Junior drew attention after opening up about his dieting experience and claiming, “There definitely is an obesity gene.”

People taking semaglutide for weight loss maintained a significantly lower calorie intake after 60 weeks on the medication, according to a new study

GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance plans continue to restrict access. Researchers at the University of Mississippi are investigating the financial and practical reasons behind those limits, along with the consequences for patients

Wegovy, Mounjaro’s global craze has surprise winner: Korean body composition analyzer maker InBody – KED Global

Weight loss drugs such like Wegovy and Mounjaro could be linked to a drop in the amount of people who are dependent on alcohol being admitted to hospital

Novo Nordisk sued Eli Lilly on July 21 over what Novo said is false and misleading advertising comparing the effectiveness of the drug companies’ respective injectable weight-loss medicines